אדסל פוליו

Țară: Israel

Limbă: ebraică

Sursă: Ministry of Health

Ingredient activ:

DIPHTHERIA TOXOID; FILAMENTOUS HAEMAGGLUTININ (FHA); FIMBRAE TUPES 2 + 3 (FIM); INACTIVATED POLIO VIRUS (IPV) TYPE 1; INACTIVATED POLIO VIRUS (IPV) TYPE 2; INACTIVATED POLIO VIRUS (IPV) TYPE 3; PERTACTIN (PRN); PERTUSSIS TOXOID VACCINE; TETANUS TOXOID

Disponibil de la:

SANOFI ISRAEL LTD

Codul ATC:

J07CA02

Forma farmaceutică:

תרחיף להזרקה

Compoziție:

FIMBRAE TUPES 2 + 3 (FIM) 5 MCG/DOSE; PERTUSSIS TOXOID VACCINE 2.5 MCG/DOSE; FILAMENTOUS HAEMAGGLUTININ (FHA) 5 MCG/DOSE; PERTACTIN (PRN) 3 MCG/DOSE; DIPHTHERIA TOXOID 2 LF / 1 DOSES; TETANUS TOXOID 5 LF / 1 DOSES; INACTIVATED POLIO VIRUS (IPV) TYPE 1 40 DU/DOSE; INACTIVATED POLIO VIRUS (IPV) TYPE 2 8 DU/DOSE; INACTIVATED POLIO VIRUS (IPV) TYPE 3 32 DU/DOSE

Calea de administrare:

תוך-שרירי

Tip de prescriptie medicala:

מרשם נדרש

Produs de:

SANOFI PASTEUR, FRANCE

Grupul Terapeutică:

DIPHTHERIA-PERTUSSIS-POLIOMYELITIS-TETANUS

Zonă Terapeutică:

DIPHTHERIA-PERTUSSIS-POLIOMYELITIS-TETANUS

Indicații terapeutice:

Active immunization against diphtheria, tetanus, pertussis and poliomyelitis in subjects aged 3 years and over as a booster following primary immunisation . Adacel polio is not indicatd for primary immunisation. Adacel polio is not indicated for treating diseases caused by B. pertussis, C.Diphtheriae or c. tetani or by poliomyelitis infections.

Data de autorizare:

2015-01-31